| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.56B | 38.90B | 38.35B | 37.69B | 38.47B | 39.28B |
| Gross Profit | 2.79B | 3.16B | 2.74B | 2.45B | 2.88B | 2.99B |
| EBITDA | 2.67B | 2.91B | 2.61B | 2.31B | 2.71B | 2.91B |
| Net Income | 1.02B | 2.72B | 957.48M | 2.50B | 950.83M | 1.24B |
Balance Sheet | ||||||
| Total Assets | 47.90B | 51.32B | 48.86B | 47.81B | 47.03B | 43.78B |
| Cash, Cash Equivalents and Short-Term Investments | 7.41B | 10.50B | 6.84B | 5.95B | 6.50B | 6.11B |
| Total Debt | 13.73B | 13.54B | 13.89B | 13.65B | 16.04B | 14.14B |
| Total Liabilities | 24.33B | 24.45B | 25.45B | 25.29B | 27.07B | 24.69B |
| Stockholders Equity | 23.54B | 26.85B | 23.37B | 22.49B | 19.93B | 19.06B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.01B | 422.75M | -854.23M | -1.55B | -725.34M |
| Operating Cash Flow | 0.00 | 3.21B | 2.59B | 1.96B | 2.88B | 2.20B |
| Investing Cash Flow | 0.00 | 1.32B | -1.80B | -1.94M | -4.29B | -2.09B |
| Financing Cash Flow | 0.00 | -1.04B | 104.97M | -2.54B | 1.80B | -412.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥19.68B | 11.05 | ― | 2.46% | 0.69% | 11.33% | |
72 Outperform | ¥7.97B | 2.98 | ― | 1.67% | 1.44% | 184.02% | |
65 Neutral | ¥23.88B | 11.42 | ― | 2.82% | 2.71% | -5.60% | |
64 Neutral | ¥5.75B | 7.47 | ― | 1.62% | 8.05% | 65.93% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥250.97B | 14.37 | 4.72% | 1.66% | 5.32% | 71.96% | |
54 Neutral | ¥3.43B | 20.34 | ― | 0.72% | 3.33% | 70.02% |